about
White coats and fingerprints: diagnostic reasoning in medicine and investigative methods of fictional detectives.Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-AnalysisCombined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: a case series.Frequency, determinants, and clinical relevance of acute coronary syndrome-like electrocardiographic findings in patients with acute aortic syndrome.Syncope and risk of sudden death in hypertrophic cardiomyopathy.A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy.Guideline of transthyretin-related hereditary amyloidosis for clinicians.Different types of cardiomyopathy associated with isolated ventricular noncompaction.Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.Cardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costs.Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography.Cardiac resynchronization by pacing: an electrical treatment of heart failure.Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance.The empowerment of translational research: lessons from laminopathies.Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA).Accuracy of non-invasive techniques for diagnosis of coronary artery disease and prediction of cardiac events in patients with left bundle branch block: a meta-analysis.Cardiac resynchronization therapy in clinical practice: need for electrical, mechanical, clinical and logistic synchronization.How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint.Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death.Transthyretin-related amyloidoses and the heart: a clinical overview.Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases."My parents died of myocardial infarction: is that my destiny?".Cardiac involvement in hereditary-transthyretin related amyloidosis.Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention.Nuclear imaging for cardiac amyloidosis.Cardiac amyloidosis: the great pretender.Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.Heart failure with preserved ejection fraction: uncertainties and dilemmas.The Mediterranean diet: a cultural journey.Transesophageal echocardiography-guided algorithm for stent-graft implantation in aortic dissection.Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation.[Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].The Italian Registry for hypertrophic cardiomyopathy: a nationwide survey.The elusive link between aortic wall histology and echocardiographic anatomy in bicuspid aortic valve: implications for prophylactic surgery.Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.Effects of myocardial fibrosis assessed by MRI on dynamic left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: a retrospective database analysis.Long-term outcomes and causes of death after acute coronary syndrome in patients in the Bologna, Italy, area.Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.
P50
Q24535795-C1268B79-EAFE-4366-8600-8062324D1789Q28263271-8D3B8A91-8061-48EB-9E41-8373B89728A6Q30444028-E1F39773-87E5-4DF8-B636-A41D2A6E2805Q33155497-8BB2C38F-E282-4B1F-984E-C0A39738544FQ33157231-6B0A0684-FEAE-463C-9D0D-C4DA39C80AB0Q33163399-6B8C4BB2-1588-4E88-B4B6-F2756B18726AQ34210855-7453AEF1-EFEF-4A79-83E6-31A3A60D0802Q34328734-7235EBEE-A891-4635-A112-B29BD983D379Q34570544-BE6E6129-EF81-468F-AAB5-D4F8864FC774Q35002777-B8297BCB-4078-46A6-B3A6-621E8D67EBE6Q35201110-CA312754-3049-4F60-AA79-0BE987164D62Q35581671-4C769D63-9AE3-4C8F-B9F9-901CC3A35144Q35584270-A00AE01D-8B1E-4BCB-98CC-3526620BA64EQ35749587-52415D47-3931-4C9C-84F8-B87DB0A3844BQ35771353-5AB14956-7F2A-4F57-9A61-6EF9839D6938Q36281672-E0B48D05-0D44-410C-97C0-4996BC4388C6Q36533003-CECFC782-66B8-4171-BDF8-CA13C512756FQ36539084-2BADA153-D27B-48D7-8A9F-A86E84033357Q36745486-5CC2B7A9-6B47-483D-BB9C-967DA9F54226Q36762559-8F8834E1-5183-4C0F-9A9E-78CD54BCB8A9Q36802605-7A6539C3-3AEB-4380-A66E-11F0C3B907E6Q37755977-F1B35A4D-DFFA-4ECC-9089-752C883DC860Q37786123-F759ECCD-7A7A-4AA3-81B5-4E4E8B591591Q37990664-98D2C01F-A344-435E-A739-C8BB777E4C45Q38001756-DA4E988F-20F0-40D0-A08C-48EB95B3BEA6Q38212464-0DFECD05-829B-4F37-AB5F-93D7A30BA36EQ38271439-76A84FA8-75AC-4C69-8D3F-FCC7D10A1EFAQ38372860-06067DA4-9E3A-4F49-8FD0-C5653DEEE4E4Q38380479-A377E5F2-0776-4DA5-ABFE-F326B8C9BBE2Q38529003-3A5647F1-35CC-4835-B4BD-FB7AE338427BQ38569077-65100E79-6F25-4BCE-AE04-9A62EEBD5B81Q38701728-A949128D-CF6F-4DB1-B1A3-7A7E885665F0Q39021551-9639BDCE-FBB2-4BE8-B3F7-6B468865FA33Q39204312-2301638B-3EE2-4189-9466-07E1E49A239DQ39359192-C74A6B8D-E417-4C11-AFC7-66D004CB48F9Q39720545-34F6BD25-E9AF-4AF2-9D69-D9B153EBBD50Q40388294-DEE0D771-8C01-4364-A5A7-EEBAD27A2913Q41503820-2F8F618B-0F73-47A0-A879-958AB197D408Q41623836-BE881FAA-3571-4E52-A88C-68879125388EQ41724575-25D639F8-C653-4E92-850D-F9CC7CAD49CF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claudio Rapezzi
@ast
Claudio Rapezzi
@en
Claudio Rapezzi
@es
Claudio Rapezzi
@nl
Claudio Rapezzi
@sl
type
label
Claudio Rapezzi
@ast
Claudio Rapezzi
@en
Claudio Rapezzi
@es
Claudio Rapezzi
@nl
Claudio Rapezzi
@sl
prefLabel
Claudio Rapezzi
@ast
Claudio Rapezzi
@en
Claudio Rapezzi
@es
Claudio Rapezzi
@nl
Claudio Rapezzi
@sl
P106
P1153
7005883289
P21
P31
P496
0000-0002-9198-2657